|
PIGC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.760400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.915010E-01 |
| Normal-vs-Stage2 |
1.515190E-01 |
| Normal-vs-Stage3 |
4.786700E-04 |
| Normal-vs-Stage4 |
2.426500E-02 |
| Stage1-vs-Stage2 |
3.941600E-01 |
| Stage1-vs-Stage3 |
2.021300E-03 |
| Stage1-vs-Stage4 |
4.376100E-02 |
| Stage2-vs-Stage3 |
8.957700E-02 |
| Stage2-vs-Stage4 |
6.274200E-02 |
| Stage3-vs-Stage4 |
4.689000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.678800E-03 |
| Normal-vs-AfricanAmerican |
2.257800E-02 |
| Normal-vs-Asian |
5.029500E-02 |
| Caucasian-vs-AfricanAmerican |
9.803800E-01 |
| Caucasian-vs-Asian |
5.194800E-01 |
| AfricanAmerican-vs-Asian |
5.116600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.618500E-02 |
| Normal-vs-Female |
1.442890E-04 |
| Male-vs-Female |
3.002500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.958300E-02 |
| Normal-vs-Extreme_Weight |
9.349900E-02 |
| Normal-vs-Obese |
9.135800E-03 |
| Normal-vs-Extreme_Obese |
8.246200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.275000E-01 |
| Normal_Weight-vs-Obese |
8.642400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.633800E-01 |
| Extreme_Weight-vs-Obese |
1.774770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.951000E-01 |
| Obese-vs-Extreme_Obese |
2.097800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.759200E-04 |
| Normal-vs-Age(41-60Yrs) |
6.598500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.511230E-01 |
| Normal-vs-Age(81-100Yrs) |
7.750800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.171600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.175600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.172800E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.496200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.217000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.229020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.241600E-02 |
| Normal-VS-Type2 PRCC |
9.379500E-02 |
| Normal-VS-KIRP CIMP |
4.46450000000098E-05 |
| Normal-VS-Unclassified PRCC |
2.266200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.930600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.33226762955019E-15 |
| Type1 PRCC-VS-Unclassified PRCC |
3.054800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.27369994738092E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
4.659600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.99839999892993E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.379210E-01 |
| Normal-vs-N1 |
5.51039999999725E-05 |
| Normal-vs-N2 |
1.415640E-03 |
| N0-vs-N1 |
4.169900E-04 |
| N0-vs-N2 |
5.027900E-02 |
| N1-vs-N2 |
5.318400E-01 |
|
|
